Click here for more information about Peginterferon alfa-2 [clinicaltrials_resource:eb46e4c489a9fd975fbf67d910bfc5ac]
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children [clinicaltrials:NCT00006325]Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) [clinicaltrials:NCT00051077]Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [clinicaltrials:NCT00239733]
link [clinicaltrials_vocabulary:link]
Click here for more information about Peginterferon alfa-2 [clinicaltrials_resource:eb46e4c489a9fd975fbf67d910bfc5ac]
Bio2RDF identifier
eb46e4c489a9fd975fbf67d910bfc5ac
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:eb46e4c489a9fd975fbf67d910bfc5ac
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:eb46e4c489a9fd975fbf67d910bfc5ac
title
Click here for more information about Peginterferon alfa-2
@en
Click here for more information about peginterferon alfa-2
@en
type
label
Click here for more informatio ...... 6e4c489a9fd975fbf67d910bfc5ac]
@en
Click here for more informatio ...... 6e4c489a9fd975fbf67d910bfc5ac]
@en